Technical Analysis for ORTX - Orchard Therapeutics plc

Grade Last Price % Change Price Change
grade B 15.61 -2.25% -0.36
ORTX closed down 2.25 percent on Thursday, February 21, 2019, on approximately normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical ORTX trend table...

Date Alert Name Type % Chg
Feb 21 Upper Bollinger Band Walk Strength 0.00%
Feb 21 Wide Bands Range Expansion 0.00%
Feb 21 Overbought Stochastic Strength 0.00%
Feb 20 New Uptrend Bullish -2.25%
Feb 20 Volume Surge Other -2.25%
Feb 20 Wide Range Bar Range Expansion -2.25%
Feb 20 Upper Bollinger Band Walk Strength -2.25%
Feb 20 Wide Bands Range Expansion -2.25%
Feb 20 Overbought Stochastic Strength -2.25%
Feb 20 Upper Bollinger Band Touch Strength -2.25%

Older signals for ORTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: ???
Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies. Orchard’s advanced portfolio of autologous ex vivo gene therapies targets serious and life-threatening rare diseases, initially primary immune deficiencies, neurometabolic disorders and hemoglobinopathies.
Biotechnology Health Biopharmaceutical Nature Therapy Hemoglobinopathies
Is ORTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Feb 6 Orchard Therapeutics Announces Acceptance of Late-Breaking Abstracts of OTL-101 for ADA-SCID and OTL-102 for X-CGD at the 2019 Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Jan 22 Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
Jan 7 Orchard Therapeutics provides 2019 strategic priorities
Jan 7 Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
Jan 2 Orchard Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019
Dec 28 2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma
Dec 17 Positive Data From Orchard Therapeutics Turns Goldman Sachs Bullish
Dec 14 Orchard Therapeutics and SIRION Biotech inks deal to enhance gene therapy manufacturing efficiency
Dec 13 Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay
Dec 13 Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
See more ORTX news...
Indicators
Indicator Value
52 Week High 19.24
52 Week Low 8.65
Average Volume 53,710
200-Day Moving Average 0.0
50-Day Moving Average 13.9119
20-Day Moving Average 13.7885
10-Day Moving Average 14.902
Average True Range 1.125
ADX 28.04
+DI 31.1533
-DI 9.3302
Chandelier Exit (Long, 3 ATRs ) 14.595
Chandelier Exit (Short, 3 ATRs ) 15.125
Upper Bollinger Band 16.4073
Lower Bollinger Band 11.1697
Percent B (%b) 0.85
BandWidth 37.985278
MACD Line 0.5782
MACD Signal Line 0.2521
MACD Histogram 0.3261
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.95
Resistance 3 (R3) 17.02 16.66 16.72
Resistance 2 (R2) 16.66 16.32 16.62 16.65
Resistance 1 (R1) 16.13 16.11 15.95 16.06 16.57
Pivot Point 15.77 15.77 15.68 15.73 15.77
Support 1 (S1) 15.24 15.43 15.06 15.17 14.65
Support 2 (S2) 14.88 15.22 14.84 14.57
Support 3 (S3) 14.35 14.88 14.50
Support 4 (S4) 14.28